Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
Authors
Keywords
-
Journal
Infectious Diseases and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-17
DOI
10.1007/s40121-022-00597-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii
- (2021) Jiaqi Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins
- (2021) Florian Wagenlehner et al. CLINICAL MICROBIOLOGY AND INFECTION
- In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
- (2021) Jacinda C. Abdul-Mutakabbir et al. Antibiotics-Basel
- Advances in Bacteriophage Therapy against Relevant MultiDrug-Resistant Pathogens
- (2021) Antonio Broncano-Lavado et al. Antibiotics-Basel
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia
- (2021) G. Dimopoulos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection
- (2021) Joonhyeok Choi et al. Pharmaceutics
- Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
- (2020) Lei Zha et al. ADVANCES IN THERAPY
- Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
- (2020) Gennaro De Pascale et al. Annals of Intensive Care
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2020) Jiating Liu et al. Journal of Global Antimicrobial Resistance
- Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study
- (2020) Alessandro Russo et al. Infectious Diseases and Therapy
- Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis
- (2019) Hekun Mei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
- (2019) Michael S Niederman et al. LANCET INFECTIOUS DISEASES
- Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
- (2018) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality
- (2018) Andrés Martín-Aspas et al. Infection and Drug Resistance
- In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
- (2018) Krystyna M. Kazmierczak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin Monotherapy Versus Colistin and Rifampin Combination Therapy in Pneumonia Caused by Colistin-resistant Acinetobacter baumannii: A Randomized Controlled Trial
- (2018) Hye Jung Park et al. Journal of Global Antimicrobial Resistance
- Managing Acinetobacter baumannii infections
- (2018) José Garnacho-Montero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Intravenous Minocycline: A Review in Acinetobacter Infections
- (2016) Sarah L. Greig et al. DRUGS
- Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
- (2016) D. Koulenti et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
- (2016) Lindsey M. Weiner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
- (2016) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
- (2014) Matthieu Boisson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
- (2014) David J. Ritchie et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumanniiEmerging as a Multidrug-Resistant Skin and Soft-Tissue Pathogen
- (2014) Brandon L. Adler et al. JAMA Dermatology
- Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness
- (2013) Rafael López-Rojas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
- (2013) Gerald A Denys et al. Annals of Clinical Microbiology and Antimicrobials
- Aerosolized Antibiotics for Ventilator-associated Pneumonia
- (2012) Jean-Jacques Rouby et al. ANESTHESIOLOGY
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
- (2012) D. F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumanniiSkin and Soft‐Tissue Infection Associated with War Trauma
- (2008) Peter J. Sebeny et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search